Emedgene
Emedgene
AI-powered platform for automated genetic interpretation and discovery in clinical labs.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does Emedgene do?
Emedgene provides the world's first completely automated genetic interpretation platform, leveraging advanced AI to scale genetic interpretation and discovery. Their solution aims to improve dry lab efficiency for clinical labs, significantly reducing the time spent on interpretation and research.
How much funding has Emedgene raised?
Emedgene has raised a total of $6M in funding. The most recent round on record is Series A.
Where is Emedgene headquartered?
Emedgene is headquartered in Tel Aviv, Israel.
When was Emedgene founded?
Emedgene was founded in 2016.
What industry does Emedgene operate in?
Emedgene operates in Healthcare, Genomics, Genomic Data, HealthTech, MedTech, AI-Driven Drug Discovery.
How many employees does Emedgene have?
Emedgene has approximately 12 people on record.
What is Emedgene's current status?
Emedgene's current operating status is: Inactive.